PATENT CLAIM ANALYSIS

Application Number: 16191693
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["435", "060000"]

Abstract:
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH 2  or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Claim (Index 6):
The method of  claim 1 , wherein the disease or disorder is attention deficit hyperactivity disorder (ADHD), Parkinson's Disease, Huntington's chorea, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, convulsions, Tourette syndrome, obsessive compulsive disorder (OCD), memory deficits and dysfunction, a learning deficit, a panic disorder, narcolepsy, nociception, AIDS dementia, autism, tardive dyskinesia, social phobia, or pseudodementia.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.25455
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15398427', '14643275', '11823312', '12262896', '12638880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6201116096481426
- 35 USC 102 Novelty (BERT): 0.5267263522473219
- Combined Prediction Score: 0.6107730839080605
- Mean Citation Score: 265.025034
- Max Citation Score: 295.0835600000001
- Similarity Product: 150.23823246863608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test